Clinical Trial Update: Transfer Factor Efficacy in the Management of Cirrhosis-associated Immune Dysfunction [Phase 2, Phase 3]

View source ↗

Summary

The clinical trial evaluating transfer factor for cirrhosis-associated immune dysfunction was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Liver Failure

Drugs mentioned

• Transfer Factor (transfer factor)

Snippet

Sponsor: Martin Janičko | Conditions: Cirrhosis, Liver Failure | Phase 2, Phase 3 | Status: WITHDRAWN